Inhibitor

Results: 3217



#Item
1ProteinSafeTM Protease Inhibitor Cocktail (100×)

ProteinSafeTM Protease Inhibitor Cocktail (100×)

Add to Reading List

Source URL: www.transgen.com.cn

- Date: 2017-10-09 00:36:23
    2Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric

    Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric

    Add to Reading List

    Source URL: www.cellcentric.com

    Language: English - Date: 2018-04-17 06:58:57
      3Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

      Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

      Add to Reading List

      Source URL: www.eumbrella.org

      Language: English - Date: 2016-02-26 09:44:29
        4Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

        Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

        Add to Reading List

        Source URL: apac-asia.com

        Language: English - Date: 2017-05-01 03:53:28
          5Aging Cell, pp872–884 Doi: acelLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an a-glucosidase inhibitor or a

          Aging Cell, pp872–884 Doi: acelLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an a-glucosidase inhibitor or a

          Add to Reading List

          Source URL: pcwww.liv.ac.uk

          Language: English - Date: 2016-09-08 18:38:10
            6FOR IMMEDIATE RELEASE Tokyo, January 12, 2018 Top-line Results of the Topical JTE-052 JAK Inhibitor Phase 3 Clinical Study (Comparative Study) in Japan

            FOR IMMEDIATE RELEASE Tokyo, January 12, 2018 Top-line Results of the Topical JTE-052 JAK Inhibitor Phase 3 Clinical Study (Comparative Study) in Japan

            Add to Reading List

            Source URL: www.torii.co.jp

            Language: English - Date: 2018-01-11 20:24:46
              7Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Alliso

              Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Alliso

              Add to Reading List

              Source URL: engelmanlab.med.harvard.edu

              Language: English - Date: 2013-05-21 15:55:24
                8Journal of Cellular Biochemistry 103:972–Raf Kinase Inhibitor Protein Positively Regulates Cell–Substratum Adhesion While Negatively Regulating Cell–Cell Adhesion Kevin T. Mc Henry,1 Roberto Montesano,2

                Journal of Cellular Biochemistry 103:972–Raf Kinase Inhibitor Protein Positively Regulates Cell–Substratum Adhesion While Negatively Regulating Cell–Cell Adhesion Kevin T. Mc Henry,1 Roberto Montesano,2

                Add to Reading List

                Source URL: biochemweb.net

                Language: English - Date: 2015-09-29 23:11:38
                  9Dries 1 Annika Dries Human Biology 158G Final Project 6 December 2013 The PARP inhibitor: the promises and challenges of targeted breast cancer therapy

                  Dries 1 Annika Dries Human Biology 158G Final Project 6 December 2013 The PARP inhibitor: the promises and challenges of targeted breast cancer therapy

                  Add to Reading List

                  Source URL: biochem158.stanford.edu

                  Language: English - Date: 2013-12-15 18:24:45
                    10A narrow spectrum kinase inhibitor, RV1729, induces bronchodilation of human small airways and rescues agonist-induced desensitization of the β2 adrenoreceptor (β2AR) 1 Koziol-White , 1

                    A narrow spectrum kinase inhibitor, RV1729, induces bronchodilation of human small airways and rescues agonist-induced desensitization of the β2 adrenoreceptor (β2AR) 1 Koziol-White , 1

                    Add to Reading List

                    Source URL: ritms.rutgers.edu

                    - Date: 2018-01-11 17:19:27